Breast Cancer
-
Exercise Benefits in Metastatic Breast Cancer
Study finds supervised physical activity can help improve quality of life and reduce fatigue among people with metastatic breast cancer.
by Thomas Celona
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
-
Germline Genetic Testing Lags Behind Guidelines
Low rates of germline genetic testing in cancer patients means information that could affect treatment isn’t available.
by Jon Kelvey
-
Making Treatment Decisions
It’s not always clear what to do when cancer progresses. Abigail Johnston shares how she has approached treatment decisions since her metastatic breast cancer diagnosis in 2017.
by Abigail M. Johnston
-
Forward Look
The Chemotherapy Choice
Adding an anthracycline to taxane chemotherapy regimens can reduce recurrence risk in early-stage breast cancer, but side effects also factor into treatment decisions.
by Kris Conner
-
Survivor Profile
Changing Course
Initially diagnosed with ductal carcinoma in situ, Sabrina Mayhew’s persistence in seeking out experts would lead to tumor testing that indicated she could safely forgo chemotherapy.
by Queen Muse
-
ADCs Make Their Mark
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
-
Forward Look
New Hormonal Therapy Pill for Advanced Breast Cancer
New oral hormonal therapy offers alternative to injections for some women with metastatic disease.
by Kris Conner
-
Forward Look
Pausing Treatment for Pregnancy
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
by Carolyn Bernhardt
-
Sex and Gender Minorities Face Disparities in Breast Cancer Care
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
